Support the World Alliance for Wound and Lymphedema care

I had a great discussion with Dr. John Macdonald the Secretariat of the World Alliance for Wound and Lymphedema Care (WAWLC) . John is an amazing individual who was one of the first physicians on the ground in Haiti (He ran the operation through the University of Miami).  John and his friends have since gone on to provide country wide wound care initiatives for any third world nation that is requesting the assistance of the WAWLC. Please support John and the WAWLC’s mission to care for those less fortunate with wounds or lymphedema through out the world. If you get a chance please take a look at their website www.wawlc.org

Wound Care Tool Kit – Drawtex

Drawtex (SteadMed) is a new find as a hydroconductive debridement agent. I was able to see an average reduction in slough of up to 75% in the eight patients I have tried it on so far. The assumed mode of action is through the dressings ability to forcefully remove drainage (up to 150cc/hr) and content from the wound into the dressing. The force of the fluid transferred into the hydroconductive dressing is able to cleave the denuded collagen that bonds the necrotic tissue from the healthy tissue. The advantage of hydroconductive debridement is that it is a top down debridement tool that can debride over a large surface area (versus the peripherial wound area such as side down debridement agents i.e. Santyl Collagenase).

Indications:

Drawtex works well with wounds with moderate to large drainage, Reoccurring slough, Adherent slough, Consolidated slough with is difficult to remove with curettage and as an alternative for patients who have pain with sharps debridement.

Author notes:

Drawtex is also useful for controlling Biofilm as noted in the  (Randy Wilcott Poster which won first place at the SAWC Spring, 2011 Conference).

The dressing will not degrade in the wound and will continue to pull fluid from high draining cavities, so it is very useful with deep narrow or wide tunnels (Were alginates fail).

Hydroconductive Debridement a new Perspective in Wound Debridement

I have long been looking for what to do once we lost Panafil and Accuzyme.  Currently, many clinicians have been using Santyl as the default wound debridement agent.  We know that Santyl  has a place in the scope of debridement, but it in itself has limitations. Needless to say, I have found what we may have been looking for as a wound debridement agent. I recently had the opportunity to finish a case study with a product that provides what I have been looking for as a debridement agent.  I will be submitted a poster on a Hydroconductive Debridement dressing called Drawtex  (SteadMed)  at the Spring 2011 SAWC . The numbers (in terms of reduction of avascular tissue) were very promising. This case study series included a average (with 8 cases) percentage reduction in the total slough and necrosis of  36% at week one, 52% at week two, and 72% at week three. Please note that no other types of debridement were utilized during this study. The study also noted an average percentage reduction in wound area of 15% at week one, 35% at week two, and 47% at week three.

Disclosure: the author receives no financial incentives from SteadMed.

University of Texas Wound Classification System of Diabetic Foot Ulcers

University of Texas Wound Classification System of Diabetic Foot Ulcers

Grade I-A: non-infected, non-ischemic superficial ulceration

Grade I-B: infected, non-ischemic superficial ulceration

Grade I-C: ischemic, non-infected superficial ulceration

Grade I-D: ischemic and infected superficial ulceration

 

Grade II-A: non-infected, non-ischemic ulcer that penetrates to capsule or bone

Grade II-B: infected, non-ischemic ulcer that penetrates to capsule or bone

Grade II-C: ischemic, non-infected ulcer that penetrates to capsule or bone

Grade II-D: ischemic and infected ulcer that penetrates to capsule or bone

 

Grade III-A: non-infected, non-ischemic ulcer that penetrates to bone or a deep abscess

Grade III-B: infected, non-ischemic ulcer that penetrates to bone or a deep abscess

Grade III-C: ischemic, non-infected ulcer that penetrates to bone or a deep abscess

Grade III-D: ischemic and infected ulcer that penetrates to bone or a deep abscess

Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998 Jan 26;158(2):157-62.

Tri-Assess Wound Care EMR stacks up well versus Wound Expert

I have had the chance to work with my friend (and nationally recognized wound guru) Cathy Thomas Hess over the last few months. We have been developing the seventh edition to her TRi-Assess wound and hyperbaric management EMR.  I have had the opportunity (in my history as a wound care clinician) to have used several wound management EMRs (including Wound Expert).  The significant difference from those EMRs to TRi-assess 7.0 is  the comprehensive, yet  intuitive flow of TRi-assess 7.0.  Tri-Assess 7.0 will also be ready to be certified as a full ambulatory solution meeting meaningful use requirements in the second quarter of this year. This is apparently in line with other wound related electronic medical records such as wound expert (woundexpert) and intellicure. If you are looking for a wound EMR system such as intellicure or wound expert (woundexpert) take a look at www.woundcarestrategies.com . I think you will be pleased with what she has to offer.

Best Wishes,

Matthew Livingston RN

Author of the Scottsdale Wound Management Guide

Follow

Get every new post delivered to your Inbox.